NCT01041781-D2
Dataset Information
Dataset ID: NCT01041781-D2
PubMed ID (PMID):
Publication Title:
Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non–Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance)
Description of Dataset:
Dataset NCT01041781-D2-Dataset.csv (c30801_ae) is one of 2 datasets associated with PubMed ID 28489511. This dataset contains information that will allow you to reproduce the adverse events analysis.
Due to further data cleaning subsequent to the JCO publication, there are slight discrepancies in the numbers of patients reporting various grade 3 adverse events from those reported in Table A3 in the publication.
Due to further data cleaning subsequent to the JCO publication, there are slight discrepancies in the numbers of patients reporting various grade 3 adverse events from those reported in Table A3 in the publication.
Data Dictionary:
Submission includes new data:
Yes
Trials Linked to Dataset
| NCT Trial Number | Disease Type |
|---|---|
| NCT01041781 |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®